Navigation Links
Artificial liver for drug tests
Date:6/25/2009

This release is available in German.

If you have hay fever, headaches or a cold, it's only a short way to the nearest chemist. The drugs, on the other hand, can take eight to ten years to develop. Until now animal experiments have been an essential step, yet they continue to raise ethical issues. "Our artificial organ systems are aimed at offering an alternative to animal experiments," says Professor Heike Mertsching of the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart. "Particularly as humans and animals have different metabolisms. 30 per cent of all side effects come to light in clinical trials." The test system, which Professor Mertsching has developed jointly with Dr. Johanna Schanz, should in future give pharmaceutical companies greater security and shorten the path to new drugs. Both researchers received the "Human-centered Technology" prize for their work.

"The special feature, in our liver model for example, is a functioning system of blood vessels," says Dr. Schanz. "This creates a natural environment for cells." Traditional models do not have this, and the cells become inactive. "We don't build artificial blood vessels for this, but use existing ones from a piece of pig's intestine." All of the pig cells are removed, but the blood vessels are preserved. Human cells are then seeded onto this structure hepatocytes, which, as in the body, are responsible for transforming and breaking down drugs, and endothelial cells, which act as a barrier between blood and tissue cells. In order to simulate blood and circulation, the researchers put the model into a computer-controlled bioreactor with flexible tube pump, developed by the IGB. This enables the nutrient solution to be fed in and carried away in the same way as in veins and arteries in humans. "The cells were active for up to three weeks," says Dr. Schan
'/>"/>

Contact: Heike Mertsching
heike.mertsching@igb.fraunhofer.de
49-711-970-4117
Fraunhofer-Gesellschaft
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Artificial Ankle Takes Giant Step Forward
2. Dr. Dean Dornic Certified to Perform Artificial Cornea Transplant
3. Automated Artificial Pancreas Controls Blood Glucose Levels in Diabetes Patients for First Time
4. Artificial liver may extend lives
5. New Video Series Spotlights Role of Biomedical Engineers in Caring for Total Artificial Heart Patients
6. INTERMACS: Total Artificial Heart Bridge-to-Transplant Rate 2x Higher at 6 Months Than BiVADS and LVADs
7. Total Artificial Heart Patient 3rd in the World to Receive Dual Transplants
8. SynCardia Introduces New 12-lb Freedom Discharge Driver Designed to Provide Quality 'Lifestyle' for Total Artificial Heart Patients
9. Artificial pump effectively backs up failing hearts
10. Researchers Successfully Create Computer-Simulated Model for Evaluating Artificial Pancreas
11. Artificial disc replacement as good or better than spinal fusion surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Artificial liver for drug tests
Artificial liver for drug tests
(Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and ... the 51st Annual Meeting of the American Society ... improved diagnostic methods for patients suffering from acute ... leukemia, and myelofibrosis that are based on a ...
(Date:12/5/2009)... launch of International Solutions, an innovative new international private medical insurance ... In addition to offering customers the flexibility to add or remove ... International Solutions enables customers to tailor their benefits to complement those ... ...
(Date:12/4/2009)... Care Investment Trust Inc. (NYSE: CRE ... Directors has declared a dividend of $0.17 per share of common ... common shareholders of record on December 14, 2009. ... Inc. is a real estate investment and finance company investing in ...
(Date:12/4/2009)... The American Association of Homes and Services for the ... Community Living and Supportive Services (CLASS) provisions remain in the ... for providing support to elders, people with disabilities and their ... health care reform bill that will make it affordable to ...
(Date:12/4/2009)... ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information ... for the "Chief Innovation Officer" Appy Award for transforming ... Award recipients are nominated based on their innovative usage ... new levels of customer success to their sales, marketing, ...
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... high-resolution panoramic imaging capability to its PreXion3D CBCT ... MATEO, Calif., May 5 PreXion, Inc. ... industrial CT systems, today announced a new high-resolution ... and the PreXion 3D Viewer, the company,s advanced ...
... were more likely to get DVT, pulmonary embolisms , , ... level of the protein albumin in urine indicates an ... veins of the lungs and legs, a Dutch study ... thrombosis (DVT), a clotting in the lower extremities which ...
... disease, but there,s a promising new procedure being performed at Abington ... ... Abington, PA (PRWEB) May 5, 2009 -- There,s new ... Memorial Hospital where doctors are performing a procedure to bypass, ...
... SAN DIEGO, May 5 ResMed Inc. (NYSE: RMD ... healthcare conferences. Kieran Gallahue, President and CEO will present at the ... New York Palace Hotel in New York City on May 13, ... Organization Development and General Counsel will present at the Deutsche Bank ...
... in Boulder, CO, and the Influenza Division of the Centers ... that the M gene version of InDevR,s FluChip can detect ... seasonal influenza viruses (A/H1N1 and A/H3N2) as well as the ... a joint team of scientists at the University of Colorado ...
... says, , , TUESDAY, May 5 (HealthDay News) -- Babies ... much greater chance of developing a respiratory tract infection, ... Permanente found an increased risk for the infection -- ... among premature infants who are put on oxygen or ...
Other Medicine News:Health News:PreXion Adds High-resolution Panoramic Imaging 2Health News:Urine Test Predicts Vein Clot Risk 2Health News:Urine Test Predicts Vein Clot Risk 3Health News:Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis 2Health News:Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis 3Health News:Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis 4Health News:InDevR's FluChip detects and distinguishes swine-origin H1N1 from human influenza viruses 2Health News:Even Barely Early Babies Face Respiratory Risks 2
(Date:12/4/2009)... 4 Drs. Neal Shore and E. David Crawford ... additional analysis of secondary end points of biochemical recurrence ... (monthly degarelix for injection) or monthly leuprolide in prostate ... Prostate cancer patients who received FIRMAGON 240/80 mg/month had ...
(Date:12/3/2009)... 3 Allen Medical Systems, a subsidiary of Hill-Rom ... the launch of its new Allen Amatech(TM) OEM (Original ... ,, The website reinforces the Allen Amatech(TM) brand ... product catalog, with detailed descriptions and design specifications for ...
(Date:12/3/2009)... 3 BioMed Realty Trust, Inc. (NYSE: BMR ... lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for ... space at The Landmark at Eastview campus in Tarrytown, New ... lease of additional space was completed approximately two months after ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3FaxBack Announces New HTTPS Fax Platform 57999 1FaxBack Announces New HTTPS Fax Platform 57999 2FaxBack Announces New HTTPS Fax Platform 57999 3 24450 000 Awarded for Innovative Asthma Research Into Death by Drowning in Mucus 57997 1 24450 000 Awarded for Innovative Asthma Research Into Death by Drowning in Mucus 57997 2Fall Chores Spark Safety Advice From Orthopaedic Surgeons 57995 1Fall Chores Spark Safety Advice From Orthopaedic Surgeons 57995 2Fall Chores Spark Safety Advice From Orthopaedic Surgeons 57995 3
... in ... ... - ABSTRACT No: 4507, BASEL, Switzerland, May 31 Adding Avastin ... with metastatic pancreatic cancer live without,their disease getting worse ("progression free survival"). ...
... N.J., May 30 Schering-Plough,Corporation (NYSE: SGP ... and oral presentations from about 60 clinical studies ... at the upcoming 44th,Annual Meeting of the American ... - June 3. Data will be presented on ...
Other Medicine Technology:Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R) 2Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R) 3About 60 Clinical Studies Regarding Schering-Plough's Oncology Compounds Will be Presented at ASCO 2
... new technology, such as a recessed scratch-resistant ... lens housings, this arthroscope has superior clarity ... EO, Steris and steam autoclaving or soaked ... post/adapters to fit ACMI, Wolf, Dyonics and ...
... Laserex Solitaire represents the latest in green laser ... use in both the operating room and clinic. ... is the premium 532nm photocoagulator. , ,The Solitaire ... has the flexibility to deliver up to 2.0 ...
... a long-term Transtelephonic dual lead ECG ... is the solution of choice for ... correlation to the patient's ECG./ ... lead loop recording information to satisfy ...
... For General Practitioners (GP'S) ... ECGs by phone to a ... 2.5 seconds per lead and ... as rhythm lead. Sequentially transmits ...
Medicine Products: